感染与接种疫苗后母乳中SARS-CoV-2特异性抗体及中和能力
本研究为前瞻性研究,连续采集产后女性母乳样本,比较自然感染与疫苗接种后母乳中抗SARS-CoV-2抗体的数量及中和能力随时间的变化。两组母乳中中和性SARS-CoV-2特异性抗体均快速升高,结合能力和IgA水平在达峰后逐渐下降;首次疫苗剂量后约150天中和活性已不可测,但疫苗加强剂量可恢复中和性IgA分泌,个体间反应水平不同。
要点
- 自然感染与疫苗接种后母乳中均出现中和性SARS-CoV-2特异性抗体快速升高。
- 两组母乳结合能力和IgA水平在达峰后均随时间逐渐下降。
- 首次疫苗剂量后约150天中和活性不可测,加强剂量可恢复中和性IgA分泌。
核心结论
- 母乳中中和性SARS-CoV-2特异性抗体在感染和疫苗接种后均快速升高,结合能力和IgA水平达峰后逐渐下降;首次疫苗剂量后约150天中和活性不可测,但疫苗加强剂量可恢复中和性IgA分泌,个体间反应水平不同。
研究设计与样本
- 前瞻性研究,通过便利抽样招募产后女性并连续采集母乳样本,比较自然感染组与疫苗接种组母乳中抗SARS-CoV-2抗体的数量及中和能力随时间的变化。
诊断标准与关键数值
- 感染组母乳IgA中位水平16.99 ng/mL(范围0-86.56),中位结合能力33.65%(范围0-67.65%)。
- 疫苗接种组母乳IgA中位水平30.80 ng/mL(范围0-77.40),中位结合能力23.80%(范围0-42.80%)。
- 首次疫苗剂量后约150天母乳中和活性不可测,疫苗加强剂量可恢复中和性IgA分泌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies have been found in breast milk following both natural SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) vaccination. This was a prospective study to evaluate the temporal changes in amount and neutralization capacity of anti-SARS-CoV-2 antibodies in breast milk stimulated by natural infection and by vaccination. Serial breast milk samples were collected from postnatal women who were recruited through convenience sampling. We found a rapid increase in neutralizing SARS-CoV-2-specific antibodies in breast milk from both study groups. Amongst the infection group, the median immunoglobulin A (IgA) level was 16.99 (range, 0-86.56) ng/mL and median binding capacity was 33.65% (range, 0-67.65%), while in the vaccination group these were 30.80 (range, 0-77.40) ng/mL and 23.80% (range, 0-42.80%), respectively. In both groups, both binding capacity and IgA levels decreased progressively over time after peaking. Neutralizing activity had become undetectable by about 150 days after the first dose of the vaccine, but a vaccine booster dose restored secretion of neutralizing IgA, albeit with different levels of response in different individuals. This highlights the importance of the vaccine booster dose in sustaining neutralizing antibody levels in breast milk, which may potentially provide protection for very young children, who cannot receive the COVID-19 vaccine. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Leung HYH, Leung BW, Gil MM, et al. SARS-CoV-2-specific antibodies and neutralization capacity in breast milk following infection vs vaccination. Ultrasound Obstet Gynecol. 2022. PMID: 35653222. doi:10.1002/uog.24965
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。